Bank of England Governor Andrew Bailey emphasizes balancing economic growth with regulatory oversight in recent BIS speech.
Andrew Bailey: Growth And Regulation
Browsing Category
Tax & Regulatory Guidance
98 posts
Michelle W Bowman: Modernizing Financial Regulation
Federal Reserve Board member Michelle Bowman discusses efforts to update financial regulation to better address current economic challenges.
Apple to report Q3 earnings following price hikes on Macs, iPads
Apple’s Q3 earnings report is expected soon, following recent price increases on Macs and iPads. The impact on sales and future outlook remains uncertain.
Capricor Investigation Notice: Levi & Korsinsky Notifies Investors Of Pending Investigation Into Capricor (CAPR)
Levi & Korsinsky notifies investors of a pending investigation into Capricor, raising concerns about potential legal action and company disclosures.
Dow Jones Industrial Average
The Dow Jones Industrial Average increased by 150 points today, driven by gains in industrial and tech stocks amid ongoing economic concerns.
ECB To Extend Use Of Climate Factors In Eurosystem Collateral Framework To Non-financial Corporate Credit Claims
The ECB announced it will extend the use of climate considerations in its Eurosystem collateral framework to include non-financial corporate credit claims, aiming to promote sustainable finance.
Zahlungsverkehrsstatistik Für Das Zweite Halbjahr 2025
Die Bundesbank hat die Zahlungsverkehrsstatistik für das zweite Halbjahr 2025 veröffentlicht, mit deutlichen Veränderungen bei digitalen und traditionellen Zahlungsmethoden.
VRRM Deadline: VRRM Investors With Losses In Excess Of $100K Have Opportunity To Lead Verra Mobility Corporation Securities Fraud Lawsuit
Investors in Verra Mobility (VRRM) with losses over $100K may now have the chance to participate in a securities fraud lawsuit, according to recent PR Newswire report.
EPR PROPERTIES Files 8-K: Material Agreement
EPR Properties has filed an 8-K with the SEC revealing a significant material agreement. Details are limited, with next steps yet to be announced.
Neuronata-R Retains Conditional Approval In South Korea
Neuronata-R retains conditional approval in South Korea, allowing continued clinical use amid ongoing review. Details on implications and next steps provided.
